Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis

Authors

Hui-fang Zhou, Washington University School of Medicine in St. Louis
Huimin Yan, Washington University School of Medicine in St. Louis
Hua Pan, Washington University School of Medicine in St. Louis
Kirk K. Hou, Washington University School of Medicine in St. Louis
Antonina Akk, Washington University School of Medicine in St. Louis
Luke E. Springer, Washington University School of Medicine in St. Louis
Ying Hu, Washington University School of Medicine in St. Louis
J. Stacy Allen, Washington University School of Medicine in St. Louis
Samuel A. Wickline, Washington University School of Medicine in St. Louis
Christine T.N. Pham, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2014

Volume

124

Issue

10

Inclusive Pages

4363-4374

Document Type

Open Access Publication

DOI

10.1172/JCI75673

Rights and Permissions

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis Hui-fang Zhou ... Samuel A. Wickline, Christine T.N. Pham Published October 1, 2014 Citation Information: J Clin Invest. 2014;124(10):4363-4374. doi:10.1172/JCI75673.

Recommended Citation

Zhou, Hui-fang; Yan, Huimin; Pan, Hua; Hou, Kirk K.; Akk, Antonina; Springer, Luke E.; Hu, Ying; Allen, J. Stacy; Wickline, Samuel A.; and Pham, Christine T.N., "Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis." The Journal of Clinical Investigation. 124, 10. 4363-4374. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3445